Skip to main content

Table 1 Patient characteristics

From: Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC

Characteristics

N (%)

No. of patients

101

 Male

83 (82)

 Female

18 (18)

Median age, years (range)

62.0 (29.8–77.7)

Smoking history

 Current smoker

53 (52.5)

 Any history of smoking

75 (74.3)

Histopathology

 Adenocarcinoma

57 (56.4)

 Adenosquamous carcinoma

4 (4)

 Squamous cell carcinoma

38 (37.6)

 Undifferentiated carcinoma

2 (2)

Median tumor size, cm (range)

5.5 (1.3–15)

Median SUVmax tumor (range)

11 (2.7–36)

Median SUVmax lymph nodes (range)

5 (1.5–19.5)

Lobar involvementa

 RUL

44 (43.6)

 RML

14 (13.9)

 RLL

9 (8.9)

 LUL

31 (30.7)

 LLL

11 (10.9)

Clinical stage

 I

16 (15.8)

 II

16 (15.8)

 III

59 (58.4)

 IV

10 (9.9)

Scans/procedures performed

 18F-FDG PET/CT

101 (100)

 CT scan

99 (98)

 EBUS/TBNA

40 (39.6)

 Mediastinoscopy

41 (40.6)

 Lymph node biopsy or dissection

57 (56.4)

  1. aMay involve multiple lobes